Select Medical Holdings Corporation (SEM)
| Market Cap | 2.05B |
| Revenue (ttm) | 5.52B |
| Net Income (ttm) | 130.13M |
| Shares Out | 124.02M |
| EPS (ttm) | 1.07 |
| PE Ratio | 15.38 |
| Forward PE | 12.54 |
| Dividend | $0.25 (1.52%) |
| Ex-Dividend Date | May 14, 2026 |
| Volume | 12,955,435 |
| Open | 16.58 |
| Previous Close | 16.55 |
| Day's Range | 16.50 - 16.58 |
| 52-Week Range | 11.65 - 16.99 |
| Beta | 0.79 |
| Analysts | Hold |
| Price Target | 16.50 (0.0%) |
| Earnings Date | Jul 30, 2026 |
About SEM
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including reha... [Read more]
Financial Performance
In 2025, Select Medical Holdings's revenue was $5.45 billion, an increase of 5.12% compared to the previous year's $5.19 billion. Earnings were $142.87 million, a decrease of -32.52%.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for SEM stock is "Hold." The 12-month stock price target is $16.5, which is no change of 0.00% from the latest price.
News
Gulfport Energy to replace Select Medical in S&P 600 at open on 7/1
Select Medical (SEM) Holdings is being acquired in a deal expected to be completed soon, pending final closing conditions.
Select Medical Holdings Corporation Announces Stockholder Approval of Acquisition by Consortium Led by Robert A. Ortenzio, Martin F.
MECHANICSBURG, Pa., June 26, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (NYSE: SEM) ("Select Medical," "we," "us," or "our") confirmed today that its previously announced Agreement and P...
Select Medical Holdings Transcript: AGM 2026
Stockholders approved both the merger and executive compensation proposals, with no questions raised during the meeting. The company will report the official vote count on Form 8-K within four business days.
$SEM Investigation Notice: BFA Law is Investigating the Select Medical Board for Breaching its Duties to Shareholders after $16.50 Acquisition Announced
NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors...
SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition – Current Shareholders Urged to Contact BFA Law
NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors...
$SEM Stock Drop Reminder: Select Medical Announces $16.50 per share Acquisition – BFA Law's Investigation into the Board is Ongoing
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors...
Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Select Medical Take-Private Transaction
SAN DIEGO, June 10, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Select Medical Holdings Corporation (NYSE:...
Select Medical Investigation: Select Medical (SEM) Board Investigated after Announcing $16.50 per share Acquisition – Contact BFA Law if You Hold Shares
NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors ...
Attention Select Medical Investors: Kaskela Law LLC is Investigating the Proposed $16.50 Per Share Shareholder Buyout and Encourages Investors to Contact the Firm to Protect Their Investment
NEWTOWN SQUARE, Pa., June 09, 2026 (GLOBE NEWSWIRE) -- Shareholder protection law firm Kaskela Law is investigating the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) (“Select ...
$SEM Securities Notice: BFA Law Notifies Select Medical Shareholders the Pending Investigation into the $16.50 per share Acquisition
NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors ...
$SEM Stock Notification: Current Shareholder of Select Medical? Contact BFA Law about its Ongoing Investigation into the Board Over $16.50 per share Acquisition
NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors...
Kaskela Law LLC Announces Investigation into Fairness of $16.50 Per Share Select Medical Holdings (SEM) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights
NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating the fairness of the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) (“Select M...
SEM Legal Claims: The Select Medical Board may have Breached its Fiduciary Duties to Investors – Contact BFA Law about its Pending Investigation into the Merger
NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors...
SEM Stock Notification: Select Medical Board Investigated for Breaching its Duties to Investors Over $16.50 Acquisition Price
NEW YORK, June 2, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and s...
SEM Shareholder Notification: Select Medical $16.50 Merger Announcement Triggers Investigation into the Board on behalf of Current Shareholders – Contact BFA Law
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors...
$SEM Securities News: BFA Law is Investigating the Select Medical Merger – Current Shareholders are Notified to Contact the Firm
NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors ...
SEM Acquisition Announcement: Select Medical Shareholders are Notified of BFA Law's Investigation into the Announced $16.50 per Share Transaction
NEW YORK--(BUSINESS WIRE)---- $SEM #Acquisition--Select Medical Shareholders are Notified of BFA Law's Investigation into the Announced $16.50 per Share Transaction.
Is $16.50 Per Share a Fair Buyout Price for Select Medical Holdings (SEM) Shareholders? Kaskela Law Encourages SEM Shareholders to Contact the Firm to Discuss Their Rights and Options to Seek Additional Compensation
NEWTOWN SQUARE, Pa., May 27, 2026 /PRNewswire/ -- Kaskela Law is investigating the recently announced proposed buyout of Select Medical Holdings Corp. (NYSE: SEM) ("Select Medical") shareholders to de...
Select Medical and Carilion Clinic form JV to operate hospital in Virginia
Select Medical (SEM) and Carilion Clinic have entered into a joint venture partnership to build and operate a new 50-bed inpatient rehabilitation hospital in Roanoke, Virginia. Select Medical will ser...
SELECT MEDICAL AND CARILION CLINIC ENTER INTO JOINT VENTURE PARTNERSHIP TO OPERATE AN INPATIENT REHABILITATION HOSPITAL IN ROANOKE, VIRGINIA
MECHANICSBURG, Pa. and ROANOKE, Va.
Select Medical Holdings Proxy statement: Proxy filing
Select Medical Holdings filed a proxy statement on May 20, 2026, providing details for shareholder voting and corporate governance matters.
Select Medical Holdings Proxy statement: Proxy filing
Select Medical Holdings filed a proxy statement on May 15, 2026, providing details for shareholder voting and corporate governance matters.
Select Medical downgraded to Neutral from Outperform at Mizuho
Mizuho analyst Ann Hynes downgraded Select Medical (SEM) to Neutral from Outperform with a price target of $16.50, down from $17. The company is being taken private with the deal…
Select Medical Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw 5% revenue growth but a 6.5% decline in adjusted EBITDA, with EPS at $0.36 adjusted for transaction costs. The take-private deal is progressing, and guidance for 2026 is unchanged. Segment growth was led by inpatient rehab, while critical illness margins were pressured by Medicare Advantage denials.
Select Medical Holdings Quarterly report: Q1 2026
Select Medical Holdings has published its Q1 2026 quarterly earnings report on May 1, 2026.